Summary:
Investigators Research Group is conducting a randomized, parallel-group, placebo-controlled, study of generic Fluticasone Propionate 100ug and Salmeterol Xinafoate 50 ug inhalation Powder compared with Advair Diskus 100/50 with patients with Asthma.
Qualified Participants Must:
• Be 12 years of age or older
•
Have been diagnosed with Asthma
•
Use Asthma medication daily and have no other lung diseases
Qualified Participants May Receive:
All study mediation will be provide, as well as study related exams, labs and breathing testing at no cost to the patient. Compensation for time and travel will be provided.